Surveillance of Pancreatic Health After Diabetes Diagnosis
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer in patients diagnosed with type 2 diabetes or with elevated sugar levels within the last 200 days. Participants will: * attend 3 study visits over 12 months time * provide a blood sample at each study visit * complete an anxiety questionnaire at each visit.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Masz od 50 do 84 lat.
- •Cukrzycę typu 2 lub wysoki poziom cukru (HbA1c >= 6.5%) zdiagnozowano w ciągu ostatnich 200 dni.
- •Zgadzasz się na pobranie do 30 ml krwi podczas każdej z 3 wizyt.
- •Zgadzasz się na wykonanie badania rezonansem (MRI) lub tomografią komputerową (CT).
- •Rozumiesz przebieg badania i chcesz wziąć w nim udział.
✗ Disqualifies
- •Chorujesz na cukrzycę typu 1 lub typu 2 od ponad 200 dni.
- •Miałeś raka trzustki, guza neuroendokrynnego trzustki lub zapalenie trzustki.
- •Jesteś obecnie diagnozowany lub leczony na raka trzustki.
- •Miałeś jakiekolwiek inne poważne zachorowanie na raka w ciągu ostatnich 3 lat.
- •Masz bardzo wysokie BMI (powyżej 40).
Simplified criteria — AI translation
Trial details
- Minimum age
- 50 Years
- Maximum age
- 84 Years
- Last updated (source)
- September 28, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (31)
Ashfields Primary Care Centre
Sandbach, United Kingdom
Maidstone and Tunbridge Wells NHS Trust
Maidstone, United Kingdom
Forest Medical Group
Leicester, United Kingdom
South Leicestershire Medical Group
Kibworth Beauchamp, United Kingdom
Peel Croft Surgery
Burton-on-Trent, United Kingdom
Kingswinford Medical Practice
Kingswinford, United Kingdom
Park Medical Centre
Leek, United Kingdom
Trinity Court Surgery
Stratford-upon-Avon, United Kingdom
Brockwood Medical Practice
Brockham, United Kingdom
Integrated Care Partnership/ The Old Cottage Hospital
Epsom, United Kingdom
Warlingham Green Medical Practice
Warlingham, United Kingdom
Ashton Medical Group
Ashton-under-Lyne, United Kingdom
Yardley Wood Health Centre
Birmingham, United Kingdom
Bournemouth Research Hub
Bournemouth, United Kingdom
Eastham Group Practice
Bromborough, United Kingdom
Willesden Medical Centre
London, United Kingdom
South Westminster Centre
London, United Kingdom
The Cuckoo Lane Practice
London, United Kingdom
Bodey Medical Centre
Manchester, United Kingdom
Bowland Medical Practice
Manchester, United Kingdom
The Maples Medical Centre
Manchester, United Kingdom
King's Mill Hospital (Sherwood Forest) Research Van
Nottingham, United Kingdom
Portsmouth Research Hub
Portsmouth, United Kingdom
Hazelvalley Family Practice
Rossendale, United Kingdom
Pembroke Centre (Hillingdon)
Ruislip, United Kingdom
Southampton Research Hub (Shirley Research Hub)
Southampton, United Kingdom
Moorgreen Hospital
Southampton, United Kingdom
Balance Street Health Centre
Uttoxeter, United Kingdom
Civic Centre
Uxbridge, United Kingdom
Quinton Practice
Walsall, United Kingdom
Weymouth Research Hub
Weymouth, United Kingdom
Trial contact
SAFE-D Trial Manager
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.